Studies have suggested that blocking miR-410 promotes HDAC1 expression, increases KLF5-mediated IKBα expression, and inhibits the NF-κB pathway, thereby inhibiting the development of atherosclerosis (Nan et al., 2021). The gene discussed is NFKB1; the disease is atherosclerosis.